EMPROVE® qualification

Request Information

Supporting Risk Assessment, Increasing Pharma Raw Materials Know-How

Emprove – Selecting the right tool for the job
With the ever increasing regulatory challenges drug manufacturers are facing, collecting information for your risk assessment can be costly and time-consuming. For its 10th anniversary, we have expanded our EMPROVE® regulatory documentation to offer you even more support for your risk assessment. What's new?:
  • Supply chain information supports transparency
  • New Product Quality Reports inform about the consistency of our products.
  • Information on elemental impurity levels of EMPROVE® products step by step/product by product
With a portfolio of 400 EMPROVE® raw materials, Merck Millipore helps you obtain standardized qualification documentation you need to smoothen your qualification and approval processes.
  • Facilitating risk assessment
  • Speed approval preparation for faster time to market
  • Time and money savings
  • Create formulations with full regulatory compliance
Merck Millipore's EMPROVE® portfolio includes the following product lines:
Our EMPROVE® dossiers comprise detailed, usage-specific documentation that includes information on manufacturing, test methods, purity and stability data, helping you to successfully navigate regulatory challenges.
Webinar: New Guideline on Elemental Impurities and its Implication - Register now!

New guideline on elemental impurities and its implications

Watch Now
Si registri per leggere la nostra rivista pharmail – più notizie, più servizi - Clicchi qui

Rivista pharmail
Più notizie, più servizi

Si registri subito!


giu 23
6. Merck Millipore Pharma Forum (German)
Merck KGaA Atrium
Darmstadt, Germany
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica Europa 20150623